We are live on
!
Find out more
RGC
Roberts, Glore & Co Portfolio holdings
AUM
$364M
1-Year Est. Return
19.54%
This Fund
S&P 500
This Quarter
Est. Return
+2.45%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$162M
AUM Growth
–
Cap. Flow
+$163M
Cap. Flow
% of AUM
100.45%
Top 10 Holdings %
Top 10 Hldgs %
32.19%
Holding
135
New
135
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$8.53M |
| 2 |
Vanguard FTSE Pacific ETF
VPL
|
+$7.72M |
| 3 |
RJI
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Total Return
RJI
|
+$7.42M |
| 4 |
Johnson & Johnson
JNJ
|
+$7.16M |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$4.1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.39% |
| 2 | Technology | 12.66% |
| 3 | Financials | 11.92% |
| 4 | Industrials | 8.11% |
| 5 | Consumer Staples | 6.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Novartis
NVS
$297B
| $1.86M | 1.15% |
+29,368
| New | +$1.91M |
|
27
Bio-Techne
TECH
$11.2B
| $1.82M | 1.12% |
+105,416
| New | +$1.75M |
|
28
Expeditors International
EXPD
$22.1B
| $1.79M | 1.11% |
+47,195
| New | +$1.77M |
|
29
M&T Bank
MTB
$35.9B
| $1.73M | 1.07% |
+15,490
| New | +$1.6M |
|
30
CME Group
CME
$96.7B
| $1.66M | 1.02% |
+21,883
| New | +$1.44M |
|
31
GE Aerospace
GE
$373B
| $1.64M | 1.01% |
+14,765
| New | +$1.63M |
|
32
AbbVie
ABBV
$448B
| $1.61M | 0.99% |
+38,989
| New | +$1.71M |
|
|
LLL
33
DELISTED
L3 Technologies, Inc.
LLL
| $1.61M | 0.99% |
+18,765
| New | +$1.57M |
|
|
NXGN
34
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.6M | 0.98% |
+85,400
| New | +$1.56M |
|
35
Paychex
PAYX
$41.5B
| $1.57M | 0.96% |
+42,895
| New | +$1.58M |
|
36
Teva Pharmaceuticals
TEVA
$40.6B
| $1.51M | 0.93% |
+38,575
| New | +$1.5M |
|
37
Abbott
ABT
$182B
| $1.38M | 0.85% |
+39,621
| New | +$1.45M |
|
38
Vanguard FTSE Emerging Markets ETF
VWO
$120B
| $1.36M | 0.84% |
+35,026
| New | +$1.47M |
|
|
39
Berkshire Hathaway Class A
BRK.A
$1.1T
| $1.35M | 0.83% |
+8
| New | +$1.32M |
|
40
Walmart Inc
WMT
$888B
| $1.34M | 0.82% |
+53,910
| New | +$1.38M |
|
41
Exelon
EXC
$47.1B
| $1.28M | 0.79% |
+58,008
| New | +$1.41M |
|
42
Becton Dickinson
BDX
$45.4B
| $1.21M | 0.74% |
+12,530
| New | +$1.19M |
|
|
DCM
43
DELISTED
NTT DOCOMO, Inc.
DCM
| $1.09M | 0.67% |
+69,525
| New | +$1.07M |
|
44
Zimmer Biomet
ZBH
$18B
| $1.03M | 0.63% |
+14,111
| New | +$1.06M |
|
45
APA Corp
APA
$13B
| $1.01M | 0.62% |
+12,059
| New | +$958K |
|
|
EMC
46
DELISTED
EMC CORPORATION
EMC
| $1.01M | 0.62% |
+42,581
| New | +$1M |
|
47
Amgen
AMGN
$207B
| $994K | 0.61% |
+10,074
| New | +$1.05M |
|
48
Baidu
BIDU
$37.4B
| $980K | 0.6% |
+10,360
| New | +$955K |
|
49
Norfolk Southern
NSC
$75.5B
| $954K | 0.59% |
+13,135
| New | +$1M |
|
50
Northern Trust
NTRS
$22.5B
| $945K | 0.58% |
+16,321
| New | +$912K |
|
Similar funds
VBFP
EW
RBFC
ACM
DCP
MA
SWA
OAJ
Roberts, Glore & Co's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Roberts, Glore & Co, which disclosed 135 positions worth $162M. Its ten largest holdings account for 32% of the portfolio.
Its largest position is Berkshire Hathaway Class B: 77,560 shares worth $8.68M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, followed by Technology and Financials.
- Roberts, Glore & Co's largest Q2 2013 buy was Berkshire Hathaway Class B: 77,560 shares worth $8.68M.
- Roberts, Glore & Co's ten largest holdings make up 32% of its $162M portfolio in Q2 2013.
- Roberts, Glore & Co disclosed 135 positions in Q2 2013, its first 13F filing on record.
Based on Roberts, Glore & Co's 13F filing for Q2 2013, filed 7 Aug 2013.